I can no longer work for a system that puts profit over access to research

The associate editor of Genomics says its publisher Elsevier effectively denies developing world access to research findings

Today I resigned from the editorial board of a well respected journal in my field – Genomics. No longer can I work for a system that provides solid profits for the publisher while effectively denying colleagues in developing countries access to research findings.

It has not been an easy decision. Some may feel that I'm grandstanding or making a futile gesture. And it may be a toxic career move. Scientists are expected to contribute to the community by reviewing papers and serving on editorial boards. But I cannot stand by any longer while access to scientific resources is restricted.

My work on biomedical research in developing countries has shown me that lack of access to current publications has a severe impact. The vast majority of biomedical scientists in Africa attempt to perform globally competitive research without up-to-date access to the wealth of biomedical literature taken for granted at western institutions. In Africa, your university may have subscriptions to only a handful of scientific journals...